Komori
Governance4523Eisai Co.,Ltd.Pharmaceuticals

Corporate Governance Report 2026/06/17

Requirements for determining the independence and neutrality of outside directors have been established, and the revisions dated 11 December 2025 are described.

Worth reading
50Recurring
Scored from 1 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Governance structure

Committee1
Nomination Committee
Changes this time

The report states that the requirements for the independence and neutrality of outside directors were revised on 11 December 2025, but the specific changes from the previous report are Not disclosed

Governance structure
ItemDetails
CommitteeNomination Committee (proportion of outside members: Not disclosed)
Changes this timeThe report states that the requirements for the independence and neutrality of outside directors were revised on 11 December 2025, but the specific changes from the previous report are Not disclosed
Items this document does not state (6)
Corporate Governance StructureNumber of directorsNumber of independent officersPolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To ensure the economic independence and neutrality of outside directors from the Company Group and specific companies, and to eliminate the risk of conflicts of interest.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Corporate Governance Report 2026/06/17 | Eisai Co.,Ltd. (4523) timely disclosure | Komori